Skip to main content

Table 3 Associations between standardised vitamin D (25 (OH) D) levels and allergic disease outcomes

From: Higher cord blood 25-hydroxyvitamin D concentrations reduce the risk of early childhood eczema: in children with a family history of allergic disease

Allergic disease outcome

Incidencea

Unadjusted RRb (95 % CI)

Adjusted RRc (95 % CI)

Adjustedc

P Value

Eczema at 1 year of age

70/265 (26.4)

0.89 (0.81, 0.97)

0.88 (0.81, 0.96)

0.002

Eczema with sensitisation at 1 year of age

19/265 (7.2)

0.85 (0.70, 1.04)

0.84 (0.69, 1.01)

0.07

Eczema at 3 years of age

77/247 (31.2)

0.94 (0.87, 1.01)

0.93 (0.86, 1.01)

0.07

Eczema with sensitisation at 3 years of age

26/244 (10.7)

0.87 (0.74, 1.02)

0.85 (0.73, 1.00)

0.051

Cumulative incidence of eczema by 3 years of age

101/250 (40.4)

0.92 (0.86, 0.98)

0.92 (0.86, 0.97)

0.005

Cumulative incidence of eczema with sensitisation by 3 years of age

30/243 (12.3)

0.85 (0.73, 0.98)

0.83 (0.72, 0.96)

0.01

IgE-mediated food allergy at 1 year of age

4/260 (1.5)

0.60 (0.41, 0.90)

-

0.01d

IgE-mediated food allergy at 3 years of age

7/229 (3.1)

0.78 (0.54, 1.13)

0.77 (0.50, 1.17)

0.22

Cumulative incidence IgE-mediated food allergy by 3 years of age

8/228 (3.5)

0.80 (0.57, 1.12)

0.78 (0.55, 1.11)

0.17

Any sensitisation at 1 year of age

36/260 (13.8)

0.95 (0.84, 1.09)

0.94 (0.83, 1.07)

0.36

Any sensitisation at 3 years of age

52/229 (22.7)

0.96 (0.87, 1.07)

0.95 (0.86, 1.05)

0.28

Cumulative incidence any sensitisation by 3 years of age

66/230 (28.7)

0.96 (0.88, 1.05)

0.95 (0.87, 1.03)

0.23

Cumulative incidence of allergic rhinitis by 3 years of age

39/246 (15.9)

0.97 (0.86, 1.10)

0.98 (0.87, 1.11)

0.80

Cumulative incidence of allergic rhinitis with sensitisation by 3 years of age

13/245 (5.3)

0.95 (0.75, 1.19)

0.94 (0.75, 1.18)

0.60

Cumulative incidence of asthma by 3 years of age

32/248 (12.9)

1.03 (0.91, 1.17)

1.03 (0.90, 1.18)

0.67

Cumulative incidence of asthma with sensitisation by 3 years of age

5/245 (2.0)

1.05 (0.74, 1.48)

-

0.80d

Cumulative incidence of any allergic disease by 3 years of age

137/240 (57.1)

0.95 (0.90, 0.99)

0.95 (0.90, 0.99)

0.02

Cumulative incidence of any allergic disease with sensitisation by 3 years of age

40/228 (17.5)

0.88 (0.78, 1.00)

0.87 (0.77, 0.98)

0.03

Respiratory tract infections by 1 year of age

45/267 (16.9)

1.08 (0.98, 1.20)

1.07 (0.97, 1.18)

0.18

Cumulative incidence of respiratory tract infections by 3 years of age

70/250 (28.0)

1.03 (0.95, 1.11)

1.02 (0.95, 1.10)

0.61

  1. RR Relative risk
  2. a Values are numbers (percentages)
  3. b Relative Risk of outcome corresponding to a 10 unit increase in standardised 25(OH)D
  4. c Adjusted for treatment group, parity, gender and maternal smoking during or leading up to pregnancy
  5. d Unadjusted p-value reported due to low incidence of outcome